AAPA Category 1 Pharmacology Credit Explained in Under 3 Minutes

The June 30th deadline is rapidly approaching. For many physician assistants and nurse practitioners, this date marks the mid-year cutoff for using 2026 CME stipends. Leaving these funds on the table is a missed opportunity to secure high-value AAPA Category 1 Pharmacology Credit and essential review materials for the NCCPA Blueprint.

If you need to satisfy state prescribing requirements or bolster your pharmacology knowledge before your budget expires, the Pharmacology Review Course and PANRE Review Course provide an efficient, high-yield solution.

Quick Logistics: Pharmacology & PANRE Review

• Price: Starting at $399.99
• Duration of Access: 30 Months
• Pharmacology Credits: 12.0 Hours of AAPA Category 1 Self-Assessment CME
• PANRE Credits: 100 Hours of AAPA Category 1 CME
• Deliverables: 120+ Pharmacology Questions | Comprehensive PANRE Question Bank
• Add-ons: $100 to $1500 Amazon or Apple Gift Cards

---

Understanding AAPA Category 1 Pharmacology Credit

AAPA Category 1 credit is the gold standard for PA continuing education. Specifically, pharmacology-designated credits are required by many state medical boards to maintain prescriptive authority, particularly for controlled substances.

While the NCCPA requires 100 CME credits every two years (with at least 50 being Category 1), they do not mandate a specific number of pharmacology hours. However, your state licensing board likely does. Furthermore, Nurse Practitioners (NPs) often require 25 pharmacology hours per 5-year recertification cycle. AAPA Category 1 Pharmacology Credit is widely accepted by the AANPCB and ANCC for these requirements.

By completing the Pharmacology Review Course before the June 30th deadline, you ensure that your 2026 CME money is utilized for credits that satisfy both national and state-level mandates.

Why the June 30th Deadline Matters

Most employer-provided CME stipends are "use it or lose it." If your fiscal year or mid-year review falls on June 30th, any remaining 2026 balance will vanish. Our CME packages allow you to add an Amazon or Apple Gift Card (up to $1500) to your purchase. This allows you to maximize your educational budget by securing both your required credits and the tools you need for further self-study, such as medical texts, hardware, or clinical supplies.

---

Clinical Case Study: Pharmacology in Practice

Your patient is a 58-year-old male with a history of hypertension and chronic kidney disease (CKD) Stage 3a. He presents for a follow-up regarding his blood pressure management. His current regimen includes Lisinopril 20mg daily. Today, his BP is 152/94 mmHg (confirmed on repeat). You decide to add a second agent.

Which of the following medications is most appropriate to add to this patient's regimen while minimizing the risk of worsening renal function?

A) Spironolactone
B) Amlodipine
C) Hydrochlorothiazide
D) Losartan

Explanation and Correct Answer

The correct answer is B) Amlodipine.

• Amlodipine is a dihydropyridine calcium channel blocker (CCB). It is highly effective for blood pressure control in patients with CKD and does not require renal dose adjustment. Unlike diuretics or additional RAAS inhibitors, it carries a lower risk of causing acute fluctuations in serum creatinine or hyperkalemia in a patient already on an ACE inhibitor.
• Spironolactone (Option A) would increase the risk of significant hyperkalemia when combined with Lisinopril, especially in the setting of Stage 3a CKD.
• Hydrochlorothiazide (Option C) loses significant efficacy as the GFR drops below 30 mL/min, and while this patient is at Stage 3a, a CCB is generally preferred as a second-line agent for its superior BP reduction in this demographic.
• Losartan (Option D) is an ARB. Combining an ACE inhibitor and an ARB is generally avoided due to the increased risk of hyperkalemia and acute kidney injury without significant additional cardiovascular benefit.

---

The 100-Hour PANRE Review Course

While the Pharmacology course focuses on medication management, the PANRE Review Course is designed for comprehensive exam preparation. It offers 100 hours of AAPA Category 1 credit, covering all organ systems identified in the NCCPA Blueprint.

Course Content Highlights:

• Cardiology: Mastery of EKG rhythms and heart failure management.
• Internal Medicine: In-depth coverage of Hospitalist medicine and chronic disease.
• Specialties: Dermatology, Orthopedics, OB/GYN, and Psychiatry.

This content was written by physician assistants for physician assistants. It is designed to be the most efficient path to passing your recertification exam while earning a massive block of Category 1 credits.

---

Practice Question: Cardiology & Pharmacology

Your patient is a 64-year-old female with a history of persistent atrial fibrillation. She is currently taking Warfarin for stroke prevention. She presents with symptoms of a urinary tract infection, and you prescribe a 3-day course of Trimethoprim-Sulfamethoxazole (TMP-SMX).

What is the most likely effect of this antibiotic on the patient’s INR?

A) Decrease the INR, increasing the risk of thrombosis.
B) Increase the INR, increasing the risk of bleeding.
C) No effect on the INR.
D) Decrease the INR, requiring an increase in Warfarin dosage.

Explanation and Correct Answer

The correct answer is B) Increase the INR, increasing the risk of bleeding.

• TMP-SMX is a potent inhibitor of the CYP2C9 enzyme, which is the primary pathway for the metabolism of S-warfarin (the more potent isomer). Inhibiting this metabolism leads to significantly increased levels of warfarin in the blood, leading to a dangerous rise in the INR.
• Clinicians must either avoid this combination or proactively reduce the warfarin dose and perform frequent INR monitoring.
• Options A, C, and D are incorrect as they do not reflect the known metabolic interaction between sulfonamides and warfarin.

---

Maximize Your 2026 CME Money Before June 30th

Don't let your professional development funds go to waste. Our packages are designed to provide the maximum return on your investment.

The CME Review Courses Advantage:

1. Efficiency: Earn 12 hours of Pharmacology credit or 100 hours of PANRE credit quickly.
2. Flexibility: Use the Amazon or Apple Gift Card add-on to buy the hardware or textbooks you need for your clinical practice.
3. Longevity: With 30 months of access, you can review the material at your own pace, long after the June 30th deadline has passed.
4. Authority: Our courses are meticulously updated to align with the NCCPA Blueprint.

Whether you are a Physician Assistant preparing for the PANRE, or a Nurse Practitioner needing pharmacology hours, our courses offer a streamlined, educational experience that respects your time and your budget.

Secure your credits and your gift card before June 30th at CMEReviewCourses.com.

---